Medicover AB (publ)
SSE:MCOV-B.ST
145.3 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 23.6 | 19.8 | 143.8 | 37.3 | 33.3 | 34.4 | 28 | 12.3 | 16.7 | 12.9 |
| Depreciation & Amortization
| 182.4 | 161.9 | 111 | 96.2 | 74.2 | 30.4 | 26.2 | 23.3 | 18 | 18.1 |
| Deferred Income Tax
| -35.3 | 0 | -20.9 | -4 | -14.8 | -13.1 | -8.6 | -3.7 | -2 | -3.2 |
| Stock Based Compensation
| 9.4 | 9.6 | 6.4 | 4.7 | 1.7 | 1.6 | 1.1 | 1.8 | 0.2 | 0.2 |
| Change In Working Capital
| -14.4 | -39.9 | -40.9 | -0.7 | -23.4 | -7.6 | 0.4 | -13.8 | -8.1 | -8.8 |
| Accounts Receivables
| -29.1 | -26.7 | -49.5 | -29.3 | -23.4 | -13.3 | -10.1 | -25.5 | -12 | -11.7 |
| Inventory
| -5.1 | 12.7 | -17.1 | -22 | -1.7 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 29.1 | 26.7 | 49.5 | 29.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 19.8 | -52.6 | -23.8 | 21.3 | 1.7 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 39.3 | 18.8 | 17.3 | 22.5 | 16.3 | -1.3 | 3.2 | 6 | 3.9 | 2.5 |
| Operating Cash Flow
| 205 | 170.2 | 216.7 | 156 | 87.3 | 44.4 | 50.3 | 25.9 | 28.7 | 21.7 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -110.5 | -140.6 | -102.2 | -72.5 | -63.2 | -41 | -29.4 | -54.3 | -30.8 | -23.6 |
| Acquisitions Net
| -5.6 | -229.1 | -87.5 | -13.6 | -82.6 | -49.3 | -24.4 | -12.1 | -15.7 | -2.3 |
| Purchases Of Investments
| -21 | -6.8 | -184.5 | -53.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 19.4 | 186.9 | 40.3 | 10.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -2.1 | 4.8 | 0.3 | 2 | 4 | -25.8 | 0.3 | 0.3 | 0.9 | 1.2 |
| Investing Cash Flow
| -119.8 | -184.8 | -333.6 | -126.3 | -141.8 | -116.1 | -53.5 | -66.1 | -45.6 | -24.7 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -397.3 | -434.7 | -54.7 | -287.8 | -479.9 | -35.6 | -174.8 | -21.1 | -114.5 | -8 |
| Common Stock Issued
| 0.3 | 0 | 0.3 | 141.9 | 0 | 0.4 | 199.3 | 2.7 | 0 | 0 |
| Common Stock Repurchased
| -0.3 | 0 | -0.3 | 0 | 0 | -0.4 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -17.9 | -17.8 | -10.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 341.5 | 428.2 | 229.2 | 131.8 | 528.7 | 100.2 | 6.8 | 59.9 | 137.1 | 12.1 |
| Financing Cash Flow
| -73.7 | -24.3 | 164.1 | -14.1 | 48.8 | 64.6 | 31.3 | 41.5 | 22.6 | 4.1 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -1.1 | -2.6 | -12 | -3.7 | 2.1 | 0.1 | -1.1 | -0.1 | -0.3 | 0.3 |
| Net Change In Cash
| 10.4 | -41.5 | 35.2 | 11.9 | -3.6 | -7 | 27 | 1.2 | 5.4 | 1.4 |
| Cash At End Of Period
| 50.8 | 40.4 | 81.9 | 46.7 | 34.8 | 38.4 | 45.4 | 18.4 | 17.2 | 11.8 |